共 50 条
- [1] Adjuvant Nivolumab or Ipilimumab + Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant NivolumabAnnals of Surgical Oncology, 2022, 29 : 2771 - 2772Tahsin M. KhanMartha E. TekeGiorgos C. KarakousisJohn T. MiuraRobert M. BrodyJonathan M. HernandezTara C. Mitchell
- [2] Adjuvant Nivolumab or Ipilimumab plus Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant NivolumabANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2771 - 2772Khan, Tahsin M.Teke, Martha E.Karakousis, Giorgos C.Miura, John T.Brody, Robert M.Hernandez, Jonathan M.Mitchell, Tara C.
- [3] Widespread vitiligo and poliosis following ipilimumab-nivolumab combination therapyJOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1278 - 1282Nemovi, KhashayarJamali, ArsiaMatinpour, KeyanDasanu, Constantin A.
- [4] Ipilimumab-nivolumab as first-line treatment in metastatic NSCLCBULLETIN DU CANCER, 2021, 108 (03) : 231 - 233El-Ghazzi, NathanLavaud, Pernelle
- [5] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanomaNATURE MEDICINE, 2018, 24 (11) : 1655 - +Blank, Christian U.Rozeman, Elisa A.Fanchi, Lorenzo F.Sikorska, Karolinavan de Wiel, BartKvistborg, PiaKrijgsman, Oscarvan den Braber, MarlousPhilips, DaisyBroeks, Annegienvan Thienen, Johannes, VMallo, Henk A.Adriaansz, Sandrater Meulens, SylviaPronk, Loes M.Grijpink-Ongering, Lindsay G.Bruining, AnnemarieGittelman, Rachel M.Warren, Sarahvan Tinteren, HarmPeeper, Daniel S.Haanen, John B. A. G.van Akkooi, Alexander C. J.Schumacher, Ton N.
- [6] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanomaNature Medicine, 2018, 24 : 1655 - 1661Christian U. BlankElisa A. RozemanLorenzo F. FanchiKarolina SikorskaBart van de WielPia KvistborgOscar KrijgsmanMarlous van den BraberDaisy PhilipsAnnegien BroeksJohannes V. van ThienenHenk A. MalloSandra AdriaanszSylvia ter MeulenLoes M. PronkLindsay G. Grijpink-OngeringAnnemarie BruiningRachel M. GittelmanSarah WarrenHarm van TinterenDaniel S. PeeperJohn B. A. G. HaanenAlexander C. J. van AkkooiTon N. Schumacher
- [7] Neoadjuvant nivolumab versus combination ipilimumab and nivolumab followed by adjuvant nivolumab in patients with resectable stage III and oligometastatic stage IV melanoma: preliminary findingsJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Reddy, Sangeetha M.Amaria, Rodabe N.Spencer, Christine N.Tetzlaff, MichaelReuben, AlexandreAndrews, MilesWang, LinghuaWoodman, ScottZhu, HaifengBlando, JorgeVence, LuisZhang, ShaojunJiang, HongGopalakrishnan, VancheswaranHudgens, CourtneyWani, KhalidaTawbi, HusseinDiab, AdiGlitza, IsabellaPatel, SapnaHwu, Wen-JenWong, MichaelHwu, PatrickCormier, JaniceLucci, AnthonyRoyal, RichardLee, Jeffrey E.Simpson, LaurenBurton, Elizabeth M.Gershenwald, Jeffrey E.Ross, MerrickAllison, JamesSharma, PadmaneeDavies, MichaelWargo, Jennifer
- [8] Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patientsFRONTIERS IN ONCOLOGY, 2022, 12Stoff, RonenGrynberg, ShirlyAsher, NethanelLaks, ShacharSteinberg, YaelSchachter, JacobShapira-Frommer, RonnieBen-Betzalel, Guy
- [9] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III MelanomaNEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1696 - 1708Blank, Christian U.Lucas, Minke W.Scolyer, Richard A.van de Wiel, Bart A.Menzies, Alexander M.Lopez-Yurda, MartaHoeijmakers, Lotte L.Saw, Robyn P. M.Lijnsvelt, Judith M.Maher, Nigel G.Pulleman, Saskia M.Gonzalez, MariaTorres Acosta, Alejandrovan Houdt, Winan J.Lo, Serigne N.Kuijpers, Anke M. J.Spillane, AndrewKlop, W. Martin C.Pennington, Thomas E.Zuur, Charlotte L.Shannon, Kerwin F.Seinstra, Beatrijs A.Rawson, Robert V.Haanen, John B. A. G.Ch'ng, SydneyNaipal, Kishan A. T.Stretch, Jonathanvan Thienen, Johannes V.Rtshiladze, Michael A.Wilgenhof, SofieKapoor, RonyMeerveld-Eggink, AafkeGrijpink-Ongering, Lindsay G.van Akkooi, Alexander C. J.Reijers, Irene L. M.Gyorki, David E.Gruenhagen, Dirk J.Speetjens, Frank M.Vliek, Sonja B.Placzke, JoannaSpain, LaviniaStassen, Robert C.Amini-Adle, MonaLebbe, CelesteFaries, Mark B.Robert, CarolineAscierto, Paolo A.van Rijn, Rozemarijnvan den Berkmortel, Franchette W. P. J.Piersma, Djura
- [10] Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic MelanomaCANCERS, 2023, 15 (01)Moura, Bianca GautronGerard, Camille L.Testart, NathalieCaikovski, MarianWicky, AlexandreAedo-Lopez, VeronicaBerthod, GregoireHomicsko, KrisztianPrior, John O.Dromain, ClarisseKandalaft, Lana E.Cuendet, Michel A.Michielin, Olivier